Biobank of Predictive Biomarkers in Genitourinary (GU) Cancers, Canada

Certification Status: Approved
Registration Status: Completed

Objective: Biobank was created to maintain a repository of blood and tissue samples for all GU cancers to be used for research at the Vancouver Prostate Centre or at other facilities/organizations involved in collaborative projects within the BC Cancer Agency. This will be used to further research regarding predictive biomarkers, mechanisms of resistance to various systemic therapies and optimal treatment selection and sequencing.

Registered Biobank Name Biobank of Predictive Biomarkers in Genitourinary (GU) Cancers
Biobank Leader Adelia
Country Canada
Email for biobank inquiries
Principal Investigator Dr. Kim Chi
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Oligo - Collection aimed at supporting several research projects, a research group or a research consortium
Biospecimen Collected: